[Alzheimer's disease. Biological and pharmacotherapeutic aspects].
D000544:Alzheimer Disease / Q000188:drug therapy / Q000503:physiopathology*; D001921:Brain / Q000503:physiopathology*; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use; D009435:Synaptic Transmission / Q000187:drug effects
D010277:Parasympathomimetics; D010830:Physostigmine
Alzheimersche Erkrankung. Biologische und pharmakotherapeutische Aspekte.